Editorial
October 4, 2023
People with idiopathic pulmonary fibrosis (IPF) or pulmonary sarcoidosis often experience both respiratory and non-respiratory symptoms. This causes a high burden of disease and a greatly reduced quality of life. A recently published Dutch study has shown this.
Idiopathic pulmonary fibrosis (IPF) and pulmonary sarcoidosis are the two most common forms of interstitial lung diseases. Common respiratory symptoms of both conditions are dyspnea and coughing. In addition, patients may experience non-respiratory complaints, such as fatigue, muscle weakness, anxiety or depression. The complaints often cause a high burden of disease and seriously reduced quality of life. But it is not known whether and to what extent these complaints differ between IPF and sarcoidosis patients, and between people with and without a respiratory disease. The study examined the respiratory and non-respiratory disease burden of multiple symptoms in IPF and sarcoidosis patients. Moreover, this disease burden has been compared with controls: people without abnormal spirometric values, FVC and FEV1.
“Patients with IPF scored higher on 11 symptoms than the control group”
Study design
The study analyzed data from 44 patients with IPF (77.3% male; mean age 70.6 years) and 45 patients with sarcoidosis (48.9% male; mean age 58.1 years). Patients were matched 1:1 to controls on sex and age. The severity of 14 symptoms was assessed with a visual analogue scale. Patients with IPF scored on 11 symptoms
Read more about:
2023-10-04 07:51:53
#high #disease #burden #IPF #pulmonary #sarcoidosis #DOQ
